Steve Shober, MS, MH, ND
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
Shober S.; Echinacea for the Common Cold. Ann Intern Med. 2003;139:600. doi: 10.7326/0003-4819-139-7-200310070-00018
Download citation file:
Published: Ann Intern Med. 2003;139(7):600.
TO THE EDITOR:
The article on echinacea by Barrett and colleagues (1) has several overt weaknesses. First, alfalfa is not an inactive herb and cannot be used as a placebo. Alfalfa has proven phytoestrogenic actions, is an alterative, detoxifies the blood, is very nutritive, and is antipyretic, any of which may explain why echinacea and alfalfa performed similarly. Were any herbalists on the study team? Just as physicians would not believe an herbalist's claims about cancer research, practitioners of alternative health will not trust this research. It would also have helped to have studied a pharmaceutical drug for a more thorough understanding of cold treatment.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only